Bioanalytical Testing Services Market to Hit $6.0 billion by 2027 | Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US)

According to the new market research report "Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027", The global bioanalytical testing services market is projected to reach USD 6.0 billion by 2027 from an estimated USD 2.9 billion in 2022, at a CAGR of 15.6% during the forecast period.

Browse in-depth TOC on "Bioanalytical Testing Services Market"
153 - Tables
37 - Figures
208 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12254971&utm_source=OPenpr&utm_campaign=paid&utm_content=referral

Increasing focus on the analytical testing of biologics and biosimilars, growing preference for outsourcing analytical testing, rising R&D expenditure in the pharmaceutical sector, are driving the growth of the market.

In this report, the global bioanalytical testing services market is segmented by type of service, application, end user, and region. Based on the type of service, the market is segmented into cell-based assays; virology testing; method development optimization and validation; serology, immunogenicity, and neutralizing antibodies; biomarker testing; pharmacokinetic testing; and other services (biologics characterization, extractable & leachable testing, and stability testing). The cell-based assays segment accounted for the largest share the bioanalytical testing services market in 2021. High and increasing utilization of cell-based assays in developing newer drugs as a result of the increasing prevalence of chronic diseases is boosting the segment growth.

Various applications considered in the market are oncology, neurology, infectious diseases, gastroenterology, cardiology, and other application areas. Among these, the oncology accounted for the largest market share in 2021, primarily due to the growing number of clinical trials conducted for oncology and the increasing prevalence of cancer globally.

The end users of bioanalytical testing services market are pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and contract research organizations (CROs). Among these, the pharmaceutical and biopharmaceutical companies segment accounted for the largest market share of the bioanalytical testing services market in 2021. Factors such as, improved outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products are driving the segment growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12254971&utm_source=OPenpr&utm_campaign=paid&utm_content=referral

Geographical Growth Scenario:

The bioanalytical testing services market is segmented into five major regions; North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America dominated this market with the largest share in 2021. This can be attributed to the presence of a well-established base of pharmaceutical and biopharmaceutical companies, rapid growth in the biosimilars and biologics markets, increasing R&D expenditure, and the large pool of bioanalytical CROs in the region.

Key Players:

Prominent players in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group (UK), Syneos Health (US), ICON (Ireland), Frontage Labs (US), PPD (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs (India), LGS Limited (UK), Sartorius AG (Germany), CD BioSciences (US), Absorption Systems LLC (US), Pace Analytical Services (US), Bioneeds India Private Limited (India) and Vipragen Biosciences (India).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12254971&utm_source=OPenpr&utm_campaign=paid&utm_content=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.